Dr. Matthew T. Ballo, MD

Dr. Ballo practices at Prisma Health Hillcrest Hospital in Simpsonville, South Carolina, part of Prisma Health.

Dr. Ballo's NPI, 1013017094, was assigned on September 22, 2006. Dr. Ballo holds Ohio license 35071913B.

Dr. Ballo's primary practice is Prisma Health Hillcrest Hospital, at 741 South East Main Street, Simpsonville, SC 29681 in Greenville County. The practice phone is (864) 454-6100. Dr. Ballo also practices at Hillcrest Hospital, 6780 Mayfield Rd, Cleveland, OH 44124.

Dr. Ballo's primary practice is Prisma Health Hillcrest Hospital in Simpsonville, South Carolina, part of Prisma Health. Dr. Ballo is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Ballo to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ballo practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Ballo's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Ballo's licenses on file in 3 states: Ohio, Tennessee and Texas.

CMS data shows 4,094 Medicare services from Dr. Ballo across 24 procedure codes in 2024, for 417 Medicare patients. Medicare paid $586,458 for them.

CMS counts 417 Medicare patients who saw Dr. Ballo in 2024. The largest group is 65 to 74, with 194 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ballo's median patient age at 72, with 39% women.

In 2024, Dr. Ballo wrote 49 Medicare Part D claims for 30 patients. 92% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $659 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Ballo for performance year 2024. Dr. Ballo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 274 general payments to Dr. Ballo from 16 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 54% of the total. Novocure Inc. paid the most, $115,022.